Successful treatment of refractory angina pectoris due to multivessel coronary spasm with valsartan

2Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

This case report describes a 78-year-old man with recurrent angina attacks due to coronary spasm. He was treated with maximum daily doses of antianginal and antioxidative medications, including isosorbide mononirate (40 mg), diltiazem (200 mg), and tocopherol nicotinate (300 mg). Despite the use of these medications, rest angina occurred 2 or 3 times during steep. Although his symptoms disappeared promptly with the use of sublingual glycerine trinitrate (GTN), an angiotensin II receptor blocker, valsartan (80 mg), was added on a daily basis with the intent of improving endothelial function and controlling his angina. After beginning 80 mg/day of valsartan, the number of the anginal attacks decreased by about 66%. The anginal attacks totally disappeared after the dose of valsartan was increased to 160 mg/day. To confirm the effect of valsartan on his angina, valsartan was stopped temporarily with his consent. His anginal attacks increased to the same frequency that was observed before valsartan; therefore, valsartan therapy was resumed. The data indicate that the addition of valsartan to maximum antianginal medications may be effective in helping to control angina attacks at rest due to coronary spasm. © 2007 The Japanese Society of Internal Medicine.

Cite

CITATION STYLE

APA

Sakamoto, T., Shintomi, Y., Yoshimura, M., & Ogawa, H. (2007). Successful treatment of refractory angina pectoris due to multivessel coronary spasm with valsartan. Internal Medicine, 46(17), 1425–1430. https://doi.org/10.2169/internalmedicine.46.0132

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free